# Aripiprazole as Augmentation for TRD

> **NCT00174876** · PHASE2 · COMPLETED · sponsor: **State University of New York - Upstate Medical University** · enrollment: 20 (—)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Drug Abilify

## Key facts

- **NCT ID:** NCT00174876
- **Lead sponsor:** State University of New York - Upstate Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** —
- **Final completion:** 2005-05
- **Target enrollment:** 20 (—)
- **Last updated:** 2008-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00174876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00174876, "Aripiprazole as Augmentation for TRD". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00174876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*